Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases - Concepedia

Concepedia

Publication | Closed Access

Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases

106

Citations

24

References

2012

Year

Tatyana V. Masyuk, Brynn N. Radtke, Angela J. Stroope, Jesús M. Bañales, Sergio A. Gradilone, Bing Huang, Anatoliy I. Masyuk, Marie C. Hogan, Vicente E. Torres, Nicholas F. LaRusso

Abstract

PAS is more effective than OCT in reducing hepatorenal cystogenesis in rodent models; therefore, it might be more beneficial for the treatment of PKD and PLD.

References

	Year	Citations

Page 1